Clinical Interests:
1.VATS for lung cancer
2.Mediastinoscopy and EBUS-TBNA for staging
3.Bronchscopy, EBUS-GS and ENB for lung cancer diagnosis
4.Neoadjuvant and adjuvant therapy for lung cancer
Bio:
|
July/1998-August/2001 |
resident physician |
Guangdong Province Zhaoqing Second Hospital |
|
August/2004-Now |
attending surgeon |
Guangdong Provincial People’s Hosiptal |
Education:
|
September/1993-July/1998 |
Bachelor Clinical Medicine |
Sun Yat-sen Medical Univeristy(SUMS) |
|
September/2001-July/2004 |
Master Oncology |
Sun Yat-sen Univeristy(SYSU) |
|
September/2013-July/2016 |
Doctor Cardiothoracic Surgery |
Guangdong Provincial Cardiovascular Institute |
Professional memberships:
Vice Young Chairman of Committee, Chinese Society of Lung Cancer, China Anti Cancer Association (CACA)
Committee member,Thoracic Surgeon of Guangdong Medical Association
Member of Chinese Society of Clincal Oncology (CSCO)
Publications:
1. Wu Si-Pei#; Liao Ri-Qiang#; Tu Hai-Yan; Wang Wen-Jun; Dong Zhong-Yi; Huang Shu-Mei; Guo Wei-Bang; Gou Lan-Ying; Sun Hui -Wen; Zhang Qi; Xie Zhi; Yan Li-Xu; Su Jian; Yang Jin-Ji; Zhong Wen-Zhao; Zhang Xu-Chao; Wu Yi-Long*. Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. J Thorac Oncol. 2018;13(4):521-532.
2. Zhong WZ, Chen KN, Chen C, Gu CD, Wang J, Yang XN, Mao WM, Wang Q, Qiao GB, Cheng Y, Xu L, Wang CL, Chen MW, Kang X, Yan W, Yan HH, Liao RQ, Yang JJ, Zhang XC, Zhou Q, Wu YL Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study.J Clin Oncol. 2019;37(25):2235-2245.
